This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
6 Oct 2020

HPNE introduces defined tubing routing for single-use facilities

Flexible support system simplifies and secures tubing paths for biopharmaceutical manufacturers.

High Purity New England (HPNE), a supplier of biopharma equipment and process systems has launched its new line of defined tubing routing (DTR), a flexible tubing support system targeted for single-use biopharmaceutical manufacturing.

This modular system holds silicon tubing securely, eliminating dips and preventing dips that occur in unsupported pressurized lines.

For the first time, skid builders, process engineers, and facilities managers have a proven, mass-produced, and versatile option specifically engineered to define supported and clean routing of single-use tubing.

DTR simplifies single-use tubing management in a cleanroom environment, with colour-coded rigid supports for easy visual identification of each tube connection.

With solid and supported bridges, even over short spans, it securely holds any length of single-use tubing.

The combination of clips and routes are mounted to brackets to provide rigid and secure support, even over long tube runs.

Portable mounting panels can be engineered to get tubing off the floor without damaging cleanroom walls.

Megan Baillie, Product Specialist at HPNE, described DTR as a “simple solution to a ubiquitous problem". She added: “Skid builders will love the versatility of this product as it can be modified for different needs, including attaching to walls, chromatography columns, and exfiltration systems.”

DTR comes in 2.9-m length, fits a wide range of clips and standard tubing sizes (6 mm–19 mm) and comes in many colours.

As the US facility installer, HPNE can customize DTR for a variety of applications, including for new builds and retrofitted into existing single-use facilities; improved aesthetic to ensure a process appears organized and secure for virtual inspections; and reduced human error and trip hazards.

Related News

  • News Federal judge blocks Colorado's unprecedented price cap on Amgen's Enbrel

    A US federal court has halted Colorado's attempt to impose a US$31,200 annual price cap on Amgen's arthritis drug Enbrel, ruling that the pharmaceutical company would likely suffer irreparable harm. The decision represents a significant blow to...
  • News Protecting life-saving therapies: CPHI Online Podcast Series

    The latest episode of the CPHI Podcast Series dives into a critical challenge facing the pharmaceutical industry: ensuring the integrity of temperature-sensitive medications and biologics through advanced predictive technology.

  • News 2026 Outsourcing Outlook Update - pharma at a crossroads

    The pharmaceutical contract development and manufacturing organisation (CDMO) sector is experiencing unprecedented transformation, driven by evolving therapeutic complexities, geopolitical tensions, and the growing demand for specialised manufacturing ...
  • News Roche maintains German investment commitment whilst rivals scale back

    Pharmaceutical giant Roche has reaffirmed its commitment to investing in Germany, standing firm even as competitors Eli Lilly and Boehringer Ingelheim dramatically reduce their planned investments in response to controversial healthcare reforms.

  • News Women in Pharma: The History of CPHI Women in Japan

    Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive.
  • News EU drafts deal to end essential medicines shortage

    European negotiators have agreed new legislation to tackle persistent shortages of essential medicines by prioritising supply security over price in public procurement and supporting domestic pharmaceutical manufacturing with strategic funding.

  • News Thermo Fisher Scientific offloads microbiology business to PE firm Astorg

    The life sciences giant is divesting its global microbiology unit, which generated $645 million in revenue last year, to the pan-European private equity firm as part of an active portfolio management strategy. The transaction is expected to close in th...
  • News The Shift: Why Sustainability is Moving to the Centre of CPHI Milan 2026

    CPHI Online contributor David Roach takes a look at how conversations around sustainability in the pharmaceutical industry can and must be transformed into actionable deliveries, and what the inaugural CPHI Sustainability Summit means for the industry.